REGULATION OF SIMIAN FOAMY VIRUS GENE EXPRESSION
猿泡沫病毒基因表达的调控
基本信息
- 批准号:2065672
- 负责人:
- 金额:$ 18.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-07-01 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The foamy viruses, or syncytium-forming viruses, are members of the
spumaviriniae sub-family of retroviruses. Foamy viruses are found in
many mammalian species and appear to be non-pathogenic in their natural
hosts even though they have a wide tissue range and induce extensive
cytopathology in cell cultures. The genomes of simian foamy virus type 1
(SFV-l) from rhesus macaque and human spumaretrovirus (HSRV) have been
molecularly cloned and sequenced; pairwise comparisons of these two
viruses show from 30% to 80% homology, depending on the region selected
for analysis. Both viruses encode several open reading frames (ORFs) in
addition to genes for virion structural proteins. Recent studies have
revealed that SFV-1 and HSRV each encode a transactivator (taf) which
functions to strongly augment transcription directed by the viral long
terminal repeat (LTR). The main objective of this proposal is to
elucidate molecular mechanisms regulating SFV-1 gene expression directed
by the viral LTR. It remains to be determined whether taf acts directly
on the LTR or whether transactivation is mediated by cellular factors.
The target (TAR) for taf is distributed over two parts of the U3 domain
of the viral LTR upstream from the TATA box in the viral promoter. Each
these two TAR regions is about 300 base pairs (bp) long and no homologies
(i.e., repeat elements) are detected between the two TARs. In addition,
the promoter-distal TAR (TAR-d) functions in only in the sense
orientation whereas the promoter-proximal TAR (TAR-p) functions in either
orientation. These observations (on the complex nature of the targets)
support the hypothesis that taf may function through more than one
cellular factor which interacts with different sequence elements in the
U3 region of the LTR.
SPECIFIC AIM 1: Binding sites for cellular factors and the precise target
sequences for taf in the SFV-1 LTR will be defined.
SPECIFIC AIM 2: Monospecific antibodies will be made to detect the SFV-1
taf gene product; taf protein in infected cells will be extensively
characterized.
SPECIFIC AIM 3: Genetically engineered yeast and mammalian cells will be
used to produce the SFV-1 taf gene product for structural and functional
studies.
SPECIFIC AIM 4: To elucidate the mechanism of SFV-1 transcriptional
transactivation, functional domains of taf will be identified by
mutagenesis and by evaluation of hybrid transactivators.
These studies on SFV-1 regulation are relevant for elucidating mechanisms
which control viral latency (or persistent infection) in the host animal.
Observations made in the course of the proposed research will also
enhance the understanding of mechanisms controlling eucaryotic
transcription; the proposed studies on SFV-1 gene expression are
significant since new (cellular) transcriptional factors may be
identified.
泡沫病毒或合胞体形成病毒是
逆转录病毒的马病毒亚科。 泡沫病毒存在于
许多哺乳动物物种,似乎是非致病性的,在他们的自然
尽管它们具有广泛的组织范围并诱导广泛的
细胞培养物中的细胞病理学。 猴泡沫病毒1型的基因组
来自恒河猴的SFV-1和人疱疹病毒(HSRV)已经被研究。
分子克隆和测序;这两个配对比较
病毒显示30%至80%的同源性,这取决于所选择的区域
用于分析 两种病毒都编码几个开放阅读框(ORF),
此外还有病毒体结构蛋白基因。 最近的研究
揭示了SFV-1和HSRV各自编码一个反式激活因子(taf),
其功能是强烈增强病毒长链指导的转录
末端重复序列(LTR)。 这项建议的主要目的是
阐明调控SFV-1基因表达的分子机制
被病毒LTR感染 TAF是否直接采取行动还有待确定
或反式激活是否由细胞因子介导。
taf的目标(TAR)分布在U3域的两个部分上
病毒启动子中TATA盒上游的病毒LTR。 每个
这两个TAR区域长约300个碱基对(bp),并且没有同源性
(i.e.,重复元件)在两个TAR之间被检测到。 此外,本发明还提供了一种方法,
启动子远端TAR(TAR-d)仅在以下意义上起作用:
而启动子近端TAR(TAR-p)在
导向 这些意见(关于目标的复杂性)
支持TAF可能通过多个机制发挥作用的假设。
细胞因子,与不同的序列元件相互作用,
LTR的U3区。
特定目的1:细胞因子的结合位点和精确靶点
将定义SFV-1 LTR中的taf序列。
特异性目的2:制备单特异性抗体以检测SFV-1
taf基因产物;感染细胞中的taf蛋白将被广泛地
表征了
具体目标3:基因工程酵母和哺乳动物细胞将被
用于产生SFV-1 taf基因产物,用于结构和功能
问题研究
具体目的4:阐明SFV-1转录的机制
反式激活,TAF的功能结构域将通过
诱变和评价杂合反式激活因子。
这些关于SFV-1调节的研究与阐明机制有关
其控制宿主动物中的病毒潜伏期(或持续感染)。
在拟议的研究过程中所作的观察也将
增强对真核生物控制机制的理解
转录; SFV-1基因表达的拟议研究是
因为新的(细胞)转录因子可能
鉴定
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Luciw其他文献
Paul Luciw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Luciw', 18)}}的其他基金
Nonhuman Primate Model for Eradication Therapy
用于根除治疗的非人类灵长类动物模型
- 批准号:
8326805 - 财政年份:2011
- 资助金额:
$ 18.04万 - 项目类别:
IMMUNOASSAYS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
检测结核分枝杆菌的免疫测定法
- 批准号:
8172553 - 财政年份:2010
- 资助金额:
$ 18.04万 - 项目类别:
IMMUNOASSAYS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
检测结核分枝杆菌的免疫测定法
- 批准号:
7959047 - 财政年份:2009
- 资助金额:
$ 18.04万 - 项目类别:
PHARMACOKINETIC STUDY OF PROSTRATIN AND PRODRUG
前列腺素及其前药的药代动力学研究
- 批准号:
7715650 - 财政年份:2008
- 资助金额:
$ 18.04万 - 项目类别: